Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II paclitaxel study in advanced or metastatic GIST after failure of imatinib, sunitinib, and regorafenib
KCT0003895Phase 2Completed
- Sponsor
- Asan Medical Center
- Start
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of paclitaxel in gastrointestinal stromal tumor (GIST), sponsored by Asan Medical Center. Primary endpoint: Disease control rate. Started Aug 2019; status: completed.
02
Drugs
paclitaxel
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on KCT0003895.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0003895.